INGN Inogen Inc.

Inogen to Announce Third Quarter 2016 Results on Thursday, November 3, 2016

GOLETA, Calif.--(BUSINESS WIRE)--

Inogen, Inc. (Nasdaq:INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release its financial results for the third quarter of 2016 after market close on Thursday, November 3, 2016. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.

Individuals interested in listening to the conference call may do so by dialing (855) 427-4393 for domestic callers or (484) 756-4258 for international callers. Please reference Conference ID: 96836773. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/.

A replay of the call will be available beginning November 3, 2016 at 4:30pm PT/7:30pm ET through 4:30pm PT/7:30pm ET on November 4, 2016. To access the replay, dial (855) 859-2056 or (404) 537-3406 and reference Conference ID: 96836773. The webcast will also be available on Inogen's website for one year following the completion of the call.

Inogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.

About Inogen

Inogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.

For more information, please visit www.inogen.com.

EN
20/10/2016

Underlying

INGNInogen Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inogen Inc.

 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 24th Annual Needham Virtual Healthcare Conference. Kevin Smith, President and Chief Executive Officer, and Michael Bourque, Chief Financial Officer, are scheduled to participate in a fireside chat on Tuesday, April 8, 2025, at 8:45 a.m. Eastern Time. A live audio webcast and archived recording of the presentation will be available to all interested parties through the page on the Inogen websit...

March 20, 2025 1 EN
 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ended December 31, 2024. “2024 was a stellar year for Inogen. With our new leadership team in place, we returned the Company to growth, achieved significant milestones, and made meaningful steps towards profitability,” said Kevin Smith, President and Chief Executive Officer. “With our leading portfolio of innovative respiratory care products, the pending introduction of Simeox ...

February 25, 2025 1 EN
 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen Announces Appointment of Mira Kirti Sahney to Board of Director...

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mira Kirti Sahney to Inogen’s Board of Directors, effective January 31, 2025. The company also announced that Tom West, who has served as a director since April 2023, retired as a member of the Board of Directors, effective January 30, 2025. “We are thrilled to welcome Mira Sahney to the Inogen Board. Mira brings considerable management, technical, and operational experience in the medical device field to Inog...

February 3, 2025 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 43.26
ZBH ZIMMER BIOMET H...
SYK STRYKER CORPORA... ... (+19)

Vermilion Compass: Weekly Equity Strategy

S&P 500 Testing Prior Breakout Level DeepSeek appears to have turned the chatbot market upside-down, putting pressure on AI-linked stocks. While the dust has yet to settle, the good news is that the selloff has been largely contained to these AI-linked stocks. The rest of the market did not seem to care; the equal-weighted S&P 500 was roughly flat yesterday. Additionally, market dynamics remain healthy, with Treasury yields, the U.S. dollar (DXY), and WTI crude oil continuing to move lower, and...

ZBH ZIMMER BIOMET HOLDINGS INC.
SYK STRYKER CORPORATION
GBX GREENBRIER COMPANIES INC.
TRN TRINITY INDUSTRIES INC.
MMSI MERIT MEDICAL SYSTEMS INC.
MDT MEDTRONIC PLC
ISRG INTUITIVE SURGICAL INC.
INGN INOGEN INC.
IART INTEGRA LIFESCIENCES HOLDINGS CORPORATION
GMED GLOBUS MEDICAL INC CLASS A
CRY CRYOLIFE INC.
PEN PENUMBRA INC.
BSX. BELO SUN MINING CORP.
SIBN GAZPROM NEFT PJSC
GATX GATX CORPORATION
RAIL FREIGHTCAR AMERICA INC.
WAB WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPORATION
OFIX ORTHOFIX MEDICAL INC.
ECOR ELECTROCORE INC.
01/29/25 January 29, 2025 1 EN
 PRESS RELEASE
Free
INGN INOGEN INC.

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline...

GOLETA, Calif.--(BUSINESS WIRE)-- (Nasdaq: ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has entered into a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ, “Yuwell”), a global home healthcare medical device manufacturer with a comprehensive portfolio of respiratory products. The strategic collaboration is expected to broaden Inogen’s product portfolio through distribution of certain respiratory products in the United States and select other territories, expand and enhan...

January 26, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch